Women are credited less in science than men.

There is a well-documented gap between the observed number of works produced by women and by men in science, with clear consequences for the retention and promotion of women1. The gap might be a result of productivity differences2-5, or it might be owing to women's contributions not being acknowledged6,7. Here we find that at least part of this gap is the result of unacknowledged contributions: women in research teams are significantly less likely than men to be credited with authorship. The findings are consistent across three very different sources of data. Analysis of the first source-large-scale administrative data on research teams, team scientific output and attribution of credit-show that women are significantly less likely to be named on a given article or patent produced by their team relative to their male peers. The gender gap in attribution is present across most scientific fields and almost all career stages. The second source-an extensive survey of authors-similarly shows that women's scientific contributions are systematically less likely to be recognized. The third source-qualitative responses-suggests that the reason that women are less likely to be credited is because their work is often not known, is not appreciated or is ignored. At least some of the observed gender gap in scientific output may be owing not to differences in scientific contribution, but rather to differences in attribution.

Authorship then and now.

A researcher should only be an author on a paper if they have contributed to it in a substantive way.

Consensus statement on measures to promote equitable authorship in the publication of research from international partnerships.

Despite the acknowledged injustice and widespread existence of parachute research studies conducted in low- or middle-income countries by researchers from institutions in high-income countries, there is currently no pragmatic guidance for how academic journals should evaluate manuscript submissions and challenge this practice. We assembled a multidisciplinary group of editors and researchers with expertise in international health research to develop this consensus statement. We reviewed relevant existing literature and held three workshops to present research data and holistically discuss the concept of equitable authorship and the role of academic journals in the context of international health research partnerships. We subsequently developed statements to guide prospective authors and journal editors as to how they should address this issue. We recommend that for manuscripts that report research conducted in low- or middle-income countries by collaborations including partners from one or more high-income countries, authors should submit accompanying structured reflexivity statements. We provide specific questions that these statements should address and suggest that journals should transparently publish reflexivity statements with accepted manuscripts. We also provide guidance to journal editors about how they should assess the structured statements when making decisions on whether to accept or reject submitted manuscripts. We urge journals across disciplines to adopt these recommendations to accelerate the changes needed to halt the practice of parachute research.

How Diverse Is Medicinal Chemistry? Insights into Race, Ethnicity, Origin, Gender, and Geography.

A bibliometric study of authors across medicinal chemistry journals over 20 years reveals important trends. Most United States (US) based authors are assigned as racially/ethnically Asian or White; few are Black or Hispanic. More US coauthors have the same race/ethnicity as the corresponding author than expected. The percentage of female authors increased globally, but only slowly. Since 2010, the number of female and male authors declined by 9% and 30%, respectively. Geographically, most authors are male except in Italy where there is gender balance. Gender homophily is observed globally. Geographically, the discipline is now more widely practiced. Article output doubled from 2000 to 2010 with a large increase in articles from China. China excepted, output has since declined. The average number of authors per article rose by a third since 2000. The value of high diversity groups in education, research, and industry cannot be overstated. We recommend diversity is addressed by every medicinal chemist.

Gender inequities in the online dissemination of scholars' work.

Unbiased science dissemination has the potential to alleviate some of the known gender disparities in academia by exposing female scholars' work to other scientists and the public. And yet, we lack comprehensive understanding of the relationship between gender and science dissemination online. Our large-scale analyses, encompassing half a million scholars, revealed that female scholars' work is mentioned less frequently than male scholars' work in all research areas. When exploring the characteristics associated with online success, we found that the impact of prior work, social capital, and gendered tie formation in coauthorship networks are linked with online success for men, but not for women-even in the areas with the highest female representation. These results suggest that while men's scientific impact and collaboration networks are associated with higher visibility online, there are no universally identifiable facets associated with success for women. Our comprehensive empirical evidence indicates that the gender gap in online science dissemination is coupled with a lack of understanding the characteristics that are linked with female scholars' success, which might hinder efforts to close the gender gap in visibility.

Alphabetical ordering of author surnames in academic publishing: A detriment to teamwork.

INTRODUCTION: In academia, many institutions use journal article publication productivity for making decisions on tenure and promotion, funding grants, and rewarding stellar scholars. Although non-alphabetical sequencing of article coauthoring by the spelling of surnames signals the extent to which a scholar has contributed to a project, many disciplines in academia follow the norm of alphabetical ordering of coauthors in journal publications. By assessing business academic publications, this study investigates the hypothesis that author alphabetical ordering disincentivizes teamwork and reduces the overall quality of scholarship. METHODS: To address our objectives, we accessed data from 21,353 articles published over a 20-year period across the four main business subdisciplines. The articles selected are all those published by the four highest-ranked journals (in each year) and four lower-ranked journals (in each year) for accounting, business technology, marketing, and organizational behavior. Poisson regression and binary logistic regression were utilized for hypothesis testing. RESULTS: This study finds that, although team size among business scholars is increasing over time, alphabetical ordering as a convention in journal article publishing disincentivizes author teamwork. This disincentive results in fewer authors per publication than for publications using contribution-based ordering of authors. Importantly, article authoring teamwork is related to article quality. Specifically, articles written by a single author typically are of lesser quality than articles published by coauthors, but the number of coauthors exhibits decreasing returns to scale-coauthoring teams of one to three are positively related to high-quality articles, but larger teams are not. Alphabetical ordering itself, however, is positively associated with quality even though it inhibits teamwork, but journal article coauthoring has a greater impact on article quality than does alphabetical ordering. CONCLUSIONS: These findings have important implications for academia. Scholars respond to incentives, yet alphabetical ordering of journal article authors conflicts with what is beneficial for the progress of academic disciplines. Based on these findings, we recommend that, to drive the highest-quality research, teamwork should be incentivized-all fields should adopt a contribution-based journal article author-ordering convention and avoid author ordering based upon the spelling of surnames. Although this study was undertaken using articles from business journals, its findings should generalize across all academia.

Whose shoulders is health research standing on? Determining the key actors and contents of the prevailing biomedical research agenda.

BACKGROUND: Conflicts of interest in biomedical research can influence research results and drive research agendas away from public health priorities. Previous agenda-setting studies share two shortfalls: they only account for direct connections between academic institutions and firms, as well as potential bias based on researchers' personal beliefs. This paper's goal is to determine the key actors and contents of the prevailing health and biomedical sciences (HBMS) research agenda, overcoming these shortfalls. METHODS: We performed a bibliometric and lexical analysis of 95,415 scientific articles published between 1999 and 2018 in the highest impact factor journals within HBMS, using the Web of Science database and the CorText platform. HBMS's prevailing knowledge network of institutions was proxied with network maps where nodes represent affiliations and edges the most frequent co-authorships. The content of the prevailing HBMS research agenda was depicted through network maps of prevalent multi-terms found in titles, keywords, and abstracts. RESULTS: The HBMS research agendas of large private firms and leading academic institutions are intertwined. The prevailing HBMS agenda is mostly based on molecular biology (40% of the most frequent multi-terms), with an inclination towards cancer and cardiovascular research (15 and 8% of the most frequent multi-terms, respectively). Studies on pathogens and biological vectors related to recent epidemics are marginal (1% of the most frequent multi-terms). Content of the prevailing HBMS research agenda prioritizes research on pharmacological intervention over research on socio-environmental factors influencing disease onset or progression and overlooks, among others, the study of infectious diseases. CONCLUSIONS: Pharmaceutical corporations contribute to set HBMS's prevailing research agenda, which is mainly focused on a few diseases and research topics. A more balanced research agenda, together with epistemological approaches that consider socio-environmental factors associated with disease spreading, could contribute to being better prepared to prevent and treat more diverse pathologies and to improve overall health outcomes.